Brief: Gensight Biologics Announces Partial Conversion Of Bonds
Dec 10 (Reuters) - Gensight Biologics SA SIGHT.PA :
* ANNOUNCES PARTIAL CONVERSION OF CONVERTIBLE BONDS AND FULL
EXERCISE OF SHARE WARRANTS BY KREOS CAPITAL
* NEW SHARES WERE LISTED ON REGULATED MARKET OF EURONEXT IN
PARIS
ON DECEMBER 10, 2020
Source text for Eikon: ID:nBw3kJ3mDa
Further company coverage: SIGHT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08